The Center of Biomedicine and Genetics (CBG) has been awarded funding to provide core services to support the California Institute for Regenerative Medicine (CIRM) Translating Center with activities related to process development and manufacturing and preclinical research necessary to obtain Investigational New Drug (IND) application, which is a prerequisite for clinical testing of cell therapy product candidates.